Nominations are open for the 2017 Power List, but will close in February 2017.

More deaths in a cancer immunotherapy trial raise questions over CAR-T safety

The 21st Century Cures Act is passed through US Congress – and includes big plans for the FDA.

Could star-shaped drug delivery capsules be the solution for ultra-long acting delivery?

Is virtual reality about to revolutionize pharmacy education and training?

Collusion, pollution, and a pricing victory for pharma in California… what’s new in business?

Our infographic shows how much can be saved with generic drugs

The FDA consults stakeholders over plans to loosen restrictions on off-label drug marketing

Is a vaccine for the common cold impossible? Scientists believe not

Patients don’t always read drug risk information – even when they say they do